SlideShare a Scribd company logo
The impact of a national oxygen register on the
adherence to guidelines for LTOT in COPD patients
Thomas Ringbæk, Hvidovre Hospital
Peter Lange, Hvidovre Hospital
Background:
Several studies have shown poor quality of
LTOT in COPD pts.
Aims of this study:
Has a national oxygen register any impact on
adherence to guidelines for LTOT:
-administration >15 hrs daily
-follow up 1-6 months after start
-no smoking
-hypoxaemia documented
Changes in prevalence, incidence, patients´
characteristics, oxygen devices, and survival
Methods
Data from The Danish Oxygen Register in
the period 1994 to 2000
The Danish Oxygen Register
established Nov. 1994
The Danish
Oxygen Register
Oxygen
suppliers
Patients´
questionnaire
Central Board of
statistics
Patients´ files
1. year
Use of O2
Subjective effect
Smoking status
Flow
Hrs/day
Oxygen devices
Responsible for LTOT
Possible stop
1. year
Diagnosis
Lung function
Blood gases
Smoking status
Diagnosis
Hospitalisation
Vital status
Covers 99% of all
Danes (5.3 mill.)
17.658 on LTOT
8.487 with COPD
Dissemination of data from
The Danish Oxygen Register
Meetings
Papers
Feedback to doctors on
request
Prevalence of COPD pts on
LTOT 1994-2000
0
5
10
15
20
25
30
35
40
45
31.10.94 31.12.95 31.12.96 31.12.97 31.12.98 31.12.99 31.12.00
per100.000
Incidence of COPD pts on LTOT
1995-2000
0
5
10
15
20
25
30
1995 1996 1997 1998 1999 2000
per100.000
Changes in patients´ characteristics,
prescription of LTOT, and delivered devices
in the period 1995 to 2000
0
10
20
30
40
50
60
70
80
90
1995 1996 1997 1998 1999 2000
%
Initiated after
admission
Outpatient clinic 1-6
months after start
Started by GP
0
10
20
30
40
50
60
70
01.11.9431.12.9531.12.9631.12.9731.12.9831.12.9931.12.00
%
Females
Age>70 yrs
Flow >1.5 L/minute
0
10
20
30
40
50
60
70
80
90
100
01.11.9431.12.9531.12.9631.12.9731.12.9831.12.9931.12.00
%
Oxygen
concentrator or
liquid oxygen
15-24 hrs/day
Mobile oxygen
Smoking status of COPD patients, residing in the central part
of Copenhagen, and on LTOT in 1995 and 2000, respectively.
0
10
20
30
40
50
60
70
80
asked yes,
smoking
CO
measured
high CO asked or
checked
smokers
1995, n= 240
2000, n= 279
p>0.05
Hypoxaemia status*.
Data from the central part of Copenhagen
Nov. 1994 31.12.2000
N=145 N=214
83%
15%
2%
72%
16%
12%
Hypoxaemic
Normoxaemic
Missing
P=0.018*) PO2 <7.3 kPa or 7.3-8.0 kPa
+ clinical signs of chronic hypoxaemia
All Danes: 57.5%
Survival rates of new COPD patients on LTOT from
Denmark compared to patients from other countries
0
10
20
30
40
50
60
70
80
90
100
0 3 6 9 12 15 18 21 24 27 30 33 36 39
Months
Cumulativesurvivalproportion(%)%)
Denmark (n=5659)
Sweden (n=403)
Belgium (n=270)
France (n=252)
Australia (n=505)
NOTT, COT (n=101)
Japan (n=4552)
Survival of COPD patients who
started LTOT in 1995 versus 1999
0,00 0,50 1,00 1,50 2,00 2,50 3,00 3,50 4,00 4,50 5,00 5,50 6,00
Years
0,0
0,2
0,4
0,6
0,8
1,0
CumSurvival
Year of start
1995
1999
Median
1.07 vs
1.40 yrs;
p=0.032
Conclusion (1)
↑ incidence and prevalence of COPD
(to 27 and 42 per 100.000)
↑ mobile oxygen
↑ started after hospitalisation
↑ age
↑ ”15-24 hrs/day”
Conclusion (2)
Only about 50% are followed up
↑ documented hypoxaemia
At least 20-25% are still smoking
↓ survival compared to other countries
↑ survival over time
Not optimal utilization of data.
Direct access to own data or current feedback?
Thank you for your attention

More Related Content

Similar to Abstract ers 2005

COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHECOPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
Devawrat Buche
 
Unit 4 Adult Health Nursing
Unit 4 Adult Health NursingUnit 4 Adult Health Nursing
Unit 4 Adult Health Nursing
sherkamalshah
 
ACO Working Group 2017
ACO Working Group 2017ACO Working Group 2017
ACO Working Group 2017
Kathryn Brown
 
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
brnmomentum
 
Home based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertensionHome based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertension
cardiositeindia
 
Copd 2006
Copd 2006Copd 2006
Copd 2006
Dang Thanh Tuan
 
COPD TALK CIPLA.pptx
COPD TALK CIPLA.pptxCOPD TALK CIPLA.pptx
COPD TALK CIPLA.pptx
lokeshlalwani8
 
COPD GOLD 2014
COPD GOLD 2014COPD GOLD 2014
COPD GOLD 2014
Sai Krishna
 
COPD 1.pptx
COPD 1.pptxCOPD 1.pptx
COPD 1.pptx
RichardArce18
 
Ipertensione Polomonare nelle malattie polmonari
Ipertensione Polomonare nelle malattie polmonariIpertensione Polomonare nelle malattie polmonari
Ipertensione Polomonare nelle malattie polmonari
PAH-GHIO
 
Ers Ats Copd Guidelines
Ers Ats Copd GuidelinesErs Ats Copd Guidelines
Ers Ats Copd Guidelines
Dang Thanh Tuan
 
Alyn morice hull wsdan 30 june 2011
Alyn morice hull wsdan 30 june 2011Alyn morice hull wsdan 30 june 2011
Alyn morice hull wsdan 30 june 2011
3GDR
 
Severe Asthma/Biomarkers Working Group ERS 2017
Severe Asthma/Biomarkers Working Group ERS 2017Severe Asthma/Biomarkers Working Group ERS 2017
Severe Asthma/Biomarkers Working Group ERS 2017
Kathryn Brown
 
COPD
COPD COPD
Copd prompt
Copd promptCopd prompt
COPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATION
COPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATIONCOPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATION
COPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATION
Dr.RMLIMS lucknow
 
Ae copd 27.5.20
Ae copd  27.5.20Ae copd  27.5.20
Ae copd 27.5.20
quehuongLX
 
COPD Working Group Meeting
COPD Working Group MeetingCOPD Working Group Meeting
COPD Working Group Meeting
Zoe Mitchell
 
copd
copdcopd
copd
Raj k
 
Dr. Fabbri
Dr. FabbriDr. Fabbri

Similar to Abstract ers 2005 (20)

COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHECOPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
 
Unit 4 Adult Health Nursing
Unit 4 Adult Health NursingUnit 4 Adult Health Nursing
Unit 4 Adult Health Nursing
 
ACO Working Group 2017
ACO Working Group 2017ACO Working Group 2017
ACO Working Group 2017
 
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
Presentació resultats Estudi multicèntric amb telemedicina Red Promete per pa...
 
Home based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertensionHome based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertension
 
Copd 2006
Copd 2006Copd 2006
Copd 2006
 
COPD TALK CIPLA.pptx
COPD TALK CIPLA.pptxCOPD TALK CIPLA.pptx
COPD TALK CIPLA.pptx
 
COPD GOLD 2014
COPD GOLD 2014COPD GOLD 2014
COPD GOLD 2014
 
COPD 1.pptx
COPD 1.pptxCOPD 1.pptx
COPD 1.pptx
 
Ipertensione Polomonare nelle malattie polmonari
Ipertensione Polomonare nelle malattie polmonariIpertensione Polomonare nelle malattie polmonari
Ipertensione Polomonare nelle malattie polmonari
 
Ers Ats Copd Guidelines
Ers Ats Copd GuidelinesErs Ats Copd Guidelines
Ers Ats Copd Guidelines
 
Alyn morice hull wsdan 30 june 2011
Alyn morice hull wsdan 30 june 2011Alyn morice hull wsdan 30 june 2011
Alyn morice hull wsdan 30 june 2011
 
Severe Asthma/Biomarkers Working Group ERS 2017
Severe Asthma/Biomarkers Working Group ERS 2017Severe Asthma/Biomarkers Working Group ERS 2017
Severe Asthma/Biomarkers Working Group ERS 2017
 
COPD
COPD COPD
COPD
 
Copd prompt
Copd promptCopd prompt
Copd prompt
 
COPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATION
COPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATIONCOPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATION
COPD:CLINICAL REVIEW AND ANESTHESIA CONSIDERATION
 
Ae copd 27.5.20
Ae copd  27.5.20Ae copd  27.5.20
Ae copd 27.5.20
 
COPD Working Group Meeting
COPD Working Group MeetingCOPD Working Group Meeting
COPD Working Group Meeting
 
copd
copdcopd
copd
 
Dr. Fabbri
Dr. FabbriDr. Fabbri
Dr. Fabbri
 

More from Thomas Ringbæk

Sygeplejersker 2009
Sygeplejersker 2009Sygeplejersker 2009
Sygeplejersker 2009
Thomas Ringbæk
 
Ltot norge2006
Ltot norge2006Ltot norge2006
Ltot norge2006
Thomas Ringbæk
 
Ltot norge2004
Ltot norge2004Ltot norge2004
Ltot norge2004
Thomas Ringbæk
 
Akursus2012a
Akursus2012aAkursus2012a
Akursus2012a
Thomas Ringbæk
 
Akursus2010
Akursus2010Akursus2010
Akursus2010
Thomas Ringbæk
 

More from Thomas Ringbæk (17)

Sygeplejersker 2009
Sygeplejersker 2009Sygeplejersker 2009
Sygeplejersker 2009
 
Ltot norge2006
Ltot norge2006Ltot norge2006
Ltot norge2006
 
Ltot norge2004
Ltot norge2004Ltot norge2004
Ltot norge2004
 
Ltot norge
Ltot norgeLtot norge
Ltot norge
 
Ltot iltfirma2004
Ltot iltfirma2004Ltot iltfirma2004
Ltot iltfirma2004
 
Ltot ama2008
Ltot ama2008Ltot ama2008
Ltot ama2008
 
Ltot2013
Ltot2013Ltot2013
Ltot2013
 
Hjemmeilt2012
Hjemmeilt2012Hjemmeilt2012
Hjemmeilt2012
 
Akursus2012a
Akursus2012aAkursus2012a
Akursus2012a
 
Akursus2012
Akursus2012Akursus2012
Akursus2012
 
Akursus2010
Akursus2010Akursus2010
Akursus2010
 
Akursus2006
Akursus2006Akursus2006
Akursus2006
 
Akursus2005
Akursus2005Akursus2005
Akursus2005
 
Akursus2003
Akursus2003Akursus2003
Akursus2003
 
Akursus2002
Akursus2002Akursus2002
Akursus2002
 
Afdelingsmøde nov 2008
Afdelingsmøde nov 2008Afdelingsmøde nov 2008
Afdelingsmøde nov 2008
 
A kursus 2014
A kursus 2014A kursus 2014
A kursus 2014
 

Abstract ers 2005

  • 1. The impact of a national oxygen register on the adherence to guidelines for LTOT in COPD patients Thomas Ringbæk, Hvidovre Hospital Peter Lange, Hvidovre Hospital
  • 2. Background: Several studies have shown poor quality of LTOT in COPD pts. Aims of this study: Has a national oxygen register any impact on adherence to guidelines for LTOT: -administration >15 hrs daily -follow up 1-6 months after start -no smoking -hypoxaemia documented Changes in prevalence, incidence, patients´ characteristics, oxygen devices, and survival
  • 3. Methods Data from The Danish Oxygen Register in the period 1994 to 2000
  • 4. The Danish Oxygen Register established Nov. 1994 The Danish Oxygen Register Oxygen suppliers Patients´ questionnaire Central Board of statistics Patients´ files 1. year Use of O2 Subjective effect Smoking status Flow Hrs/day Oxygen devices Responsible for LTOT Possible stop 1. year Diagnosis Lung function Blood gases Smoking status Diagnosis Hospitalisation Vital status
  • 5. Covers 99% of all Danes (5.3 mill.) 17.658 on LTOT 8.487 with COPD
  • 6. Dissemination of data from The Danish Oxygen Register Meetings Papers Feedback to doctors on request
  • 7. Prevalence of COPD pts on LTOT 1994-2000 0 5 10 15 20 25 30 35 40 45 31.10.94 31.12.95 31.12.96 31.12.97 31.12.98 31.12.99 31.12.00 per100.000
  • 8. Incidence of COPD pts on LTOT 1995-2000 0 5 10 15 20 25 30 1995 1996 1997 1998 1999 2000 per100.000
  • 9. Changes in patients´ characteristics, prescription of LTOT, and delivered devices in the period 1995 to 2000 0 10 20 30 40 50 60 70 80 90 1995 1996 1997 1998 1999 2000 % Initiated after admission Outpatient clinic 1-6 months after start Started by GP 0 10 20 30 40 50 60 70 01.11.9431.12.9531.12.9631.12.9731.12.9831.12.9931.12.00 % Females Age>70 yrs Flow >1.5 L/minute 0 10 20 30 40 50 60 70 80 90 100 01.11.9431.12.9531.12.9631.12.9731.12.9831.12.9931.12.00 % Oxygen concentrator or liquid oxygen 15-24 hrs/day Mobile oxygen
  • 10. Smoking status of COPD patients, residing in the central part of Copenhagen, and on LTOT in 1995 and 2000, respectively. 0 10 20 30 40 50 60 70 80 asked yes, smoking CO measured high CO asked or checked smokers 1995, n= 240 2000, n= 279 p>0.05
  • 11. Hypoxaemia status*. Data from the central part of Copenhagen Nov. 1994 31.12.2000 N=145 N=214 83% 15% 2% 72% 16% 12% Hypoxaemic Normoxaemic Missing P=0.018*) PO2 <7.3 kPa or 7.3-8.0 kPa + clinical signs of chronic hypoxaemia All Danes: 57.5%
  • 12. Survival rates of new COPD patients on LTOT from Denmark compared to patients from other countries 0 10 20 30 40 50 60 70 80 90 100 0 3 6 9 12 15 18 21 24 27 30 33 36 39 Months Cumulativesurvivalproportion(%)%) Denmark (n=5659) Sweden (n=403) Belgium (n=270) France (n=252) Australia (n=505) NOTT, COT (n=101) Japan (n=4552)
  • 13. Survival of COPD patients who started LTOT in 1995 versus 1999 0,00 0,50 1,00 1,50 2,00 2,50 3,00 3,50 4,00 4,50 5,00 5,50 6,00 Years 0,0 0,2 0,4 0,6 0,8 1,0 CumSurvival Year of start 1995 1999 Median 1.07 vs 1.40 yrs; p=0.032
  • 14. Conclusion (1) ↑ incidence and prevalence of COPD (to 27 and 42 per 100.000) ↑ mobile oxygen ↑ started after hospitalisation ↑ age ↑ ”15-24 hrs/day”
  • 15. Conclusion (2) Only about 50% are followed up ↑ documented hypoxaemia At least 20-25% are still smoking ↓ survival compared to other countries ↑ survival over time Not optimal utilization of data. Direct access to own data or current feedback?
  • 16. Thank you for your attention

Editor's Notes

  1. According to the title of our presentation, I will present data on adherence to guidelines for COPD patients on LTOT in the period 1994-2000. Secondly, I present data on diagnosis ect. in this study period.
  2. Inspired by the Swedish and French Oxygen Register, we established The Danish Oxygen Register Nov. 1994. The oxygen suppliers: All patients on LTOT. Flow, hours daily, systems, doctor prescr. The first year all patients where asked to answer a questionnaire about use of oxygen, smoking, and the subjective effect of oxygen. From the files we got information on diagnosis, lung function, blood gases etc. Central Board of Statistics: Vital status and hospitalisation
  3. The Register covers nearly all Danes on LTOT. In the study period, more than 17.000 patients had been registered, And about half of these had COPD.
  4. The data was diss. Through meetings – local as well as national Through papers – in Danish and international And feedback to doctors on request
  5. In 1994 the prevalence was about 27/100.000. I the following years, it increased by about 50% to 42/100.000
  6. New COPD patients on LTOT. A smaller increase was seen for the incidence.
  7. About 60% of the COPD patients were females with no change over time. Age and flow increased significantly. Sign. increases were seen in delivered oxygen concentrators/liquid oxygen, prescribed oxygen 15-24 hrs daily, and delivered mobile oxygen. These trends were also seen for new patients. For new patients, we observed that most started right after a hospitalisation when they were clinically unstable, and this number increased. Only about half of the patients who had LTOT after 6 months had been seen in the out-patient clinic. Unfortunately, without any improvement over time. Fewer patients had LTOT started by a GP.
  8. In a sub sample of COPD pts. on LTOT, residing in the central part of CPH and comprising about 15% of all COPD pts on LTOT in Denmark, smoking status was examined in 1995 and 2000. -about 75% of the pts were asked about smoking. -nearly 20% admitted that they smoked -a little more than 50% had carbon monooxide measured – either in the blood or in the expired air. -about 15% had too high level -when the questionnaire and CO-test were combined, nearly 80% were examined. -and 20-25% were considered current smokers. No changes over time were seen. In 1994, the same figures were seen for all COPD pts. on LTOT in Denmark.
  9. In the same sub sample of patients, hypoxaemic status was examined in 1994 and 2000. In 1994, 72% of the pts had hypoxaemia detected, and this figure increased significantly to 83% in 2000. However, this sub sample was not representative fo all patients in Denmark. In 1994, 57.5% of all pts. Had hypoxaemia detected. Compared with the rest of the country, most of the patients in CPH had LTOT prescribed by a chest physician.
  10. Our COPD patients had worse survival compared to other countries. Especially high 6-month mortality rate was seen in our patients. It is difficult to explain this. In our study, the number of patients who started LTOT right after a hospitalisation was very high, and these patients had higher mortality than patients who started LTOT in the out-patient clinic. In the NOTT study all pts. And, I believe, in the Swedish study most of the pts. had LTOT prescribed in a clinical stable condition.
  11. In the study period, the median survial time was increased by 4 months – about 30%.
  12. So far, the utilization of data from this oxygen register has not been optimal. Direct access to own data and current feedback on adherence to guidelines for COT may improve the quality. This has been practiced in patients with hernia surgery. Two and an half year after implementation of The Danish Hernia Database, the quality of operation improved significantly (109). From this database, feedback was provided to participants twice yearly, with the results for the specific participant compared with the entire database.